Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

6 clinical studies listed.

Filters:

AIS

Tundra lists 6 AIS clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

RECRUITING

NCT07520565

A Multicentre, Randomised, Double-blind, Placebo-parallel Controlled Phase Ⅲ Clinical Trial Evaluating the Efficacy and Safety of BXOS110 Injection in the Treatment of Acute Ischaemic Stroke Within 3 Hours of Onset.

The purpose of this study was to evaluate the efficacy of early administration of BXOS110 for injection in reducing overall disability in patients with acute ischaemic stroke

Gender: All

Ages: 18 Years - 85 Years

Updated: 2026-04-09

8 states

AIS
ACTIVE NOT RECRUITING

NCT07194564

Acute Training Effect Assessment in Adolescent Idiopathic Scoliosis

This study aims to assess the immediate effects of a self-corrective exercise on muscle activity and spinal alignment in adolescents with idiopathic scoliosis. Eligible participants will undergo clinical assessments of spine deviation and surface electromyography (EMG) before and after a single session of guided self-controled and self-corrective exercise. The findings may help inform rehabilitation strategies for adolescent idiopathic scoliosis.

Gender: All

Ages: 10 Years - 19 Years

Updated: 2025-10-02

1 state

Adolescence Idiopathic Scoliosis
AIS
NOT YET RECRUITING

NCT06702657

A Randomized Clinical Trial on Urgent Angioplasty for IntraCranial Atherosclerotic Stenosis-related Large-Vessel Occlusion After Mechanical Thrombectomy

A prospective, multicenter, randomized controlled, open-label, blinded outcome evaluation (PROBE) trial

Gender: All

Ages: 18 Years - Any

Updated: 2025-03-18

AIS
ICAS - Intracranial Atherosclerosis
Stroke
RECRUITING

NCT04422366

Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

This study is designed to evaluate the vaccine efficacy, immunogenicity and safety of the 9-valent Human Papillomavirus (Types 6, 11, 16, 18,31,33,45,52 and 58) Recombinant Vaccine (Hansenula Polymorpha) in Chinese Female Subjects Aged 20-45 Years .

Gender: FEMALE

Ages: 20 Years - 45 Years

Updated: 2024-06-07

1 state

Cervical Cancer
Vulvar Cancer
Vaginal Cancer
+11
RECRUITING

NCT04895020

Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years

This phase 3 study will evaluate the immunogenicity and safety of 9-valent HPV recombinant vaccine in Chinese females aged 9 to 45 years

Gender: FEMALE

Ages: 9 Years - 45 Years

Updated: 2024-04-17

HPV Infections
Cervical Cancer
Vulvar Cancer
+12
RECRUITING

NCT05466383

Screening and Intervention for AIS in Haikou, Hainan Province, China

This is a single-center, prospective, non-randomized, open-label, interventional, real-world study. The mild/moderate AIS patients will be recruited through screening of 250,000 primary and secondary school students in Haikou, Hainan Province. The patients will be treated with different non-surgical interventions (exercise intervention or brace intervention) according to the physician's recommendations and the patient's intention. Patients will be followed up for 36 months to evaluate the effectiveness and safety of non-surgical interventions in the real world.

Gender: All

Ages: 9 Years - 16 Years

Updated: 2023-08-04

1 state

AIS